Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/24/14 → 6/30/15 |
Funding
- Juventas Therapeutics Incorporated: $15,320.00
JTCS-003: A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults with Ischemic Heart Failure
- Gurley, John (PI)